Bryan Kim is the founder of Verismo Therapeutics. Verismo Therapeutics has raised $50M in total funding. Backed by HLB Innovation, DongKoo Bio, HLB.
Bryan Kim is the CEO of Verismo Therapeutics, a clinical-stage CAR T cell therapy company. The company, a spinout from the University of Pennsylvania, focuses on pioneering a novel multi-chain KIR-CAR platform technology to treat various cancers. Verismo Therapeutics has raised a total of $50 million since its inception in 2020.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide